Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)

3 november 2026 uppdaterad av: Deborah Ejem, University of Alabama at Birmingham

Refinement and Pilot Testing of the "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions in the Deep South (MyHP-South)

The goal of this clinical trial is to evaluate the feasibility and acceptability of the revised My Health Priorities (MyHP) program among rural and underserved older adults with multiple chronic conditions in the Deep South. The program is designed to help participants clarify their health-related values, as well as improve communication with family caregivers and healthcare providers to support medical decision-making. The main question this study aims to answer is whether the revised MyHP program is practical/easy for individuals to use, and if it helps support necessary conversations about healthcare priorities. Participants will be asked to complete the revised MyHP program over a Zoom or in-person session with their caregiver, as well as complete questionnaires over a telephone interview before and 12 weeks after the completion of the program. In addition to participating in the MyHP program, caregivers will also be asked to complete a series of questionnaires over a telephone interview before and 12 weeks after the program. Both patients and caregivers will also be asked to complete a brief survey about their experience with the program over a telephone interview.

Studieöversikt

Status

Har inte rekryterat ännu

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Beräknad)

44

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

  • Namn: Alexis M Johnson, B.S.
  • Telefonnummer: 205-975-1864
  • E-post: amjohns2@uab.edu

Studera Kontakt Backup

  • Namn: Deborah B Ejem, Ph.D.
  • Telefonnummer: 205-996-1671
  • E-post: tejem@uab.edu

Studieorter

    • Alabama
      • Birmingham, Alabama, Förenta staterna, 35233
        • The Whitaker Clinic of the University of Alabama at Birmingham (UAB) Hospital
        • Kontakt:
        • Kontakt:
          • Deborah B Ejem, Ph.D.
          • Telefonnummer: 205-996-1671
          • E-post: tejem@uab.edu

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria for Patients:

  1. Identifies as African American or White/Caucasian
  2. Is 65 years of age or older
  3. Has at least two of the following chronic conditions: cancer, heart disease, kidney disease, liver disease, or lung disease
  4. English-speaking and able to complete baseline study measures
  5. Cognitively able to participate in decision-making discussions
  6. Has a family caregiver that meets the eligibility requirements
  7. Has reliable telephone access

Inclusion Criteria for Caregivers:

  1. Identifies as African American or White/Caucasian
  2. Is 18 years of age or older
  3. A relative, partner, or friend who provides unpaid assistance or support with health-related decision-making (may or may not live in the same residence)
  4. English-speaking and able to complete baseline study measures
  5. Cognitively able to participate in decision-making discussions
  6. Has reliable telephone access

Exclusion Criteria for Patients:

  1. Has a documented diagnosis of dementia
  2. Is unable to understand the study and provide informed consent
  3. Resides in a nursing home or assisted living facility

Exclusion Criteria for Caregivers:

  1. Is unable to understand the study and provide informed consent
  2. Is unable to communicate with research staff
  3. Is unable to participate in the dyadic MyHP-South session and required assessments

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Hälsovårdsforskning
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: MyHP-South Users

Includes the patients and caregivers who will be utilizing the MyHP-South program, as well as evaluating its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. This arm also includes the clinicians who will be assessing the usefulness of the program in a primary care setting.

Participants will use the refined My Health Priorities South (MyHP-South) program to help identify and communicate personal health priorities, then evaluate its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Patient System Usability Scale (SUS)
Tidsram: At the MyHP-South session, within 14 days after baseline.

Over a Zoom or telephone interview, patients will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree.

At the MyHP-South session, within 14 days after baseline.
Acceptability Interview
Tidsram: At the MyHP-South session, within 14 days after baseline.

Over a Zoom or telephone interview, both patients and caregivers will together answer 26 questions regarding their experience using the revised MyHP-South tool. Answer options will be open-ended.

At the MyHP-South session, within 14 days after baseline.
Recruitment Feasibility
Tidsram: From initiation of recruitment through enrollment of the final dyad (approximately 12 months).

Indicated by the number and proportion of eligible patient-caregiver dyads who enroll.

From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
Retention and Completion Feasibility
Tidsram: From baseline through 12 weeks after the MyHP-South session.

Indicated by the number and proportion of enrolled dyads completing baseline assessments, the MyHP-South session, immediate post-session assessments, the acceptability interview, and the 12-week assessments.

From baseline through 12 weeks after the MyHP-South session.
Caregiver System Usability Scale (SUS)
Tidsram: Immediately after the MyHP-South session, during the same study visit.

Over a Zoom or telephone interview, caregivers will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree.

Immediately after the MyHP-South session, during the same study visit.

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
CollaboRATE Scale Score
Tidsram: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer three questions regarding their experience with their healthcare provider during a clinical encounter. Answer options will follow a ranked scale ranging from zero to nine and will then be calculated into a final score/percentage.

At baseline and 12 weeks after the MyHP-South session.
Treatment Burden Questionnaire (TBQ) Score
Tidsram: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer 13 questions regarding the potential burden of managing multiple chronic conditions. Answer options will follow a ranked scale ranging from zero to ten and will then be calculated into a final score.

At baseline and 12 weeks after the MyHP-South session.
Patient Shared Care Instrument Score
Tidsram: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer 19 questions regarding communication, decision making, and reciprocity with their caregiver. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales.

At baseline and 12 weeks after the MyHP-South session.
Bakas Caregiver Outcomes Scale (BCOS)
Tidsram: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, caregivers will answer 10 questions regarding potential life changes that have occurred as a result of serving as a caregiver. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from -3: changed for the worse, to +3: changed for the best.

At baseline and 12 weeks after the MyHP-South session.
Older Patient Assessment of Chronic Illness Care (O-PACIC) Scale Score
Tidsram: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, patients will answer ten questions regarding the quality of medical care they have received over the past six months. Answer options will follow a Likert-type frequency scale, which will then be calculated into a final score.

At baseline and 12 weeks after the MyHP-South session.
Caregiver Shared Care Instrument Score
Tidsram: At baseline and 12 weeks after the MyHP-South session.

Over a telephone interview, caregivers will answer 19 questions regarding communication, decision making, and reciprocity with their patient. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales.

At baseline and 12 weeks after the MyHP-South session.

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Timing Log for MyHP-South Session
Tidsram: At the MyHP-South session, within 14 days after baseline.

Research staff will document the length of each MyHP-South session by documenting what time the session started and what time the session ended. Time used to navigate technical difficulties will be subtracted. Tracking how long the session takes serves as a measure of feasibility.

At the MyHP-South session, within 14 days after baseline.
Clinician Feedback Survey
Tidsram: Within 6 months after the completion of the MyHP-South session.

Over an electronic survey, clinicians who provide care to enrolled patients will answer ten questions regarding the clarity, fit, and usefulness of the revised MyHP-South in a primary care setting.

Within 6 months after the completion of the MyHP-South session.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Deborah B Ejem, Ph.D., University of Alabama at Birmingham

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 januari 2027

Primärt slutförande (Beräknad)

31 december 2027

Avslutad studie (Beräknad)

31 december 2027

Studieregistreringsdatum

Först inskickad

29 oktober 2026

Först inskickad som uppfyllde QC-kriterierna

3 november 2026

Första postat (Faktisk)

9 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

9 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

3 november 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • IRB-300016725
  • U54AG093230 (U.S.S. NIH-anslag/kontrakt)
  • 606877 (Annan identifierare: ASSIST Study ID)
  • DGCG-11797 (Annan identifierare: NIA CROMS Study ID)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera